Found: 42
Select item for more details and to access through your institution.
Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 11, p. N.PAG, doi. 10.1093/ofid/ofy268
- By:
- Publication type:
- Article
The value of serum Wisteria floribunda agglutinin-positive human Mac-2-binding protein as a predictive marker for hepatitis C virus-related complications after systemic chemotherapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 6, p. 531, doi. 10.1159/000480143
- By:
- Publication type:
- Article
Serum inducible protein 10 kDa/C‐X‐C motif chemokine 10 levels predict regression of M2BPGi‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agents.
- Published in:
- Hepatology Research, 2024, v. 54, n. 1, p. 32, doi. 10.1111/hepr.13962
- By:
- Publication type:
- Article
Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2024, v. 54, n. 5, p. 451, doi. 10.1111/hepr.13995
- By:
- Publication type:
- Article
Identification of microRNA‐96‐5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2022, v. 52, n. 1, p. 93, doi. 10.1111/hepr.13674
- By:
- Publication type:
- Article
Influence of renal dysfunction on dose reduction and virologic efficacy of regimens combining ribavirin and all‐oral direct acting antivirals in patients with chronic hepatitis C virus infection.
- Published in:
- Hepatology Research, 2019, v. 49, n. 5, p. 512, doi. 10.1111/hepr.13311
- By:
- Publication type:
- Article
Efficacy of direct‐acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study.
- Published in:
- Hepatology Research, 2019, v. 49, n. 2, p. 125, doi. 10.1111/hepr.13256
- By:
- Publication type:
- Article
Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease.
- Published in:
- Hepatology Research, 2018, v. 48, n. 7, p. 549, doi. 10.1111/hepr.13058
- By:
- Publication type:
- Article
Changes in serum lipid profiles caused by three regimens of interferon‐free direct‐acting antivirals for patients infected with hepatitis C virus.
- Published in:
- Hepatology Research, 2018, v. 48, n. 3, p. E203, doi. 10.1111/hepr.12970
- By:
- Publication type:
- Article
Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease.
- Published in:
- Hepatology Research, 2017, v. 47, n. 11, p. 1165, doi. 10.1111/hepr.12879
- By:
- Publication type:
- Article
Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy.
- Published in:
- Hepatology Research, 2017, v. 47, n. 12, p. 1308, doi. 10.1111/hepr.12898
- By:
- Publication type:
- Article
Virological characteristics of hepatitis B genotype G/A2 recombination virus in Japan.
- Published in:
- Hepatology Research, 2016, v. 46, n. 8, p. 775, doi. 10.1111/hepr.12612
- By:
- Publication type:
- Article
Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C.
- Published in:
- Hepatology Research, 2014, v. 44, n. 12, p. 1208, doi. 10.1111/hepr.12294
- By:
- Publication type:
- Article
Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats.
- Published in:
- Hepatology Research, 2011, v. 41, n. 4, p. 375, doi. 10.1111/j.1872-034X.2010.00769.x
- By:
- Publication type:
- Article
Validation of Cross-Genotype Neutralization by Hepatitis B Virus-Specific Monoclonal Antibodies by In Vitro and In Vivo Infection.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0118062
- By:
- Publication type:
- Article
Influence of Genes Suppressing Interferon Effects in Peripheral Blood Mononuclear Cells during Triple Antiviral Therapy for Chronic Hepatitis C.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0118000
- By:
- Publication type:
- Article
Complex structural variations in non-human primate hepatitis B virus.
- Published in:
- Virology Journal, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12985-021-01667-0
- By:
- Publication type:
- Article
Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma.
- Published in:
- Molecular Cancer, 2016, v. 15, p. 1, doi. 10.1186/s12943-016-0514-6
- By:
- Publication type:
- Article
Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C.
- Published in:
- Human Genetics, 2015, v. 134, n. 3, p. 279, doi. 10.1007/s00439-014-1520-7
- By:
- Publication type:
- Article
Development of hepatocellular carcinoma from various phases of chronic hepatitis B virus infection.
- Published in:
- PLoS ONE, 2021, v. 16, n. 12, p. 1, doi. 10.1371/journal.pone.0261878
- By:
- Publication type:
- Article
Bile acid dysmetabolism in the gut‐microbiota‐liver axis under hepatitis C virus infection.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 124, doi. 10.1111/liv.15041
- By:
- Publication type:
- Article
Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease.
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0224184
- By:
- Publication type:
- Article
Novel Genetic Rearrangements Termed "Structural Variation Polymorphisms" Contribute to the Genetic Diversity of Orthohepadnaviruses.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 9, p. 871, doi. 10.3390/v11090871
- By:
- Publication type:
- Article
Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 11, p. 2840, doi. 10.1093/cid/ciz1160
- By:
- Publication type:
- Article
Gut Dysbiosis Associated With Hepatitis C Virus Infection.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 6, p. 869, doi. 10.1093/cid/ciy205
- By:
- Publication type:
- Article
Characterization of hepatitis B virus with complex structural variations.
- Published in:
- BMC Microbiology, 2018, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12866-018-1350-1
- By:
- Publication type:
- Article
A novel glycobiomarker, W isteria floribunda agglutinin macrophage colony-stimulating factor receptor, for predicting carcinogenesis of liver cirrhosis.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 6, p. 1462, doi. 10.1002/ijc.29880
- By:
- Publication type:
- Article
TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Erratum to: Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinoma.
- Published in:
- Cancer Management & Research, 2012, v. 4, p. 423, doi. 10.2147/CMAR.S38684
- By:
- Publication type:
- Article
Factors influencing distant recurrence of hepatocellular carcinoma following combined radiofrequency ablation and transarterial chemoembolization therapy in patients with hepatitis C.
- Published in:
- Cancer Management & Research, 2011, v. 3, p. 267, doi. 10.2147/CMR.S22073
- By:
- Publication type:
- Article
Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B.
- Published in:
- PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0263844
- By:
- Publication type:
- Article
Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents.
- Published in:
- Oncology, 2024, v. 102, n. 7, p. 611, doi. 10.1159/000536154
- By:
- Publication type:
- Article
Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real‐world setting: A large, multicenter study from Japan.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 8, p. 1420, doi. 10.1111/jgh.14982
- By:
- Publication type:
- Article
Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 5, p. 855, doi. 10.1111/jgh.14874
- By:
- Publication type:
- Article
Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 2, p. 364, doi. 10.1111/jgh.14447
- By:
- Publication type:
- Article
Noninvasive evaluation of hepatic fibrosis in hepatitis C virus-infected patients using ethoxybenzyl-magnetic resonance imaging.
- Published in:
- Journal of Gastroenterology & Hepatology, 2013, v. 28, n. 6, p. 1032, doi. 10.1111/jgh.12181
- By:
- Publication type:
- Article